Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8500+0.0050 (+0.59%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.8450
Open0.8450
Bid0.8289 x 1000
Ask0.8762 x 1100
Day's Range0.8304 - 0.8709
52 Week Range0.6000 - 2.3400
Volume20,184
Avg. Volume264,566
Market Cap21.443M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.7630
Earnings DateNov 14, 2022 - Nov 18, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IKT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Inhibikase Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 04/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more
Advertisement
Advertisement